Your browser doesn't support javascript.
loading
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.
Cheng, H; Ballman, K; Vassilakopoulou, M; Dueck, A C; Reinholz, M M; Tenner, K; Gralow, J; Hudis, C; Davidson, N E; Fountzilas, G; McCullough, A E; Chen, B; Psyrri, A; Rimm, D L; Perez, E A.
Afiliação
  • Cheng H; Department of Pathology, Yale University School of Medicine, 310 Cedar Street BML116, New Haven, CT 06520, USA.
  • Ballman K; Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
  • Vassilakopoulou M; Department of Medical Oncology, Pitie-Salpetriere Hospital, 83 Boulevard de l'Hôpital, 75013 Paris, France.
  • Dueck AC; Section of Biostatistics, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.
  • Reinholz MM; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
  • Tenner K; Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
  • Gralow J; Department of Medical Oncology, University of Washington/Seattle Cancer Care Alliance, 825 Eastlake Avenue East, Seattle, WA 98109, USA.
  • Hudis C; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 8, New York, NY 10065, USA.
  • Davidson NE; Division of Hematology/Oncology, University of Pittsburgh Cancer Institute and UPMC Cancer Center, 5150 Centre Avenue, Pittsburgh, PA 15232, USA.
  • Fountzilas G; 1] Department of Medical Oncology, Papageorgiou General Hospital, Aristotle University of Thessaloniki School of Medicine, Efkarpia Peripheral Road Stavroupoli, 56429 Thessaloniki, Greece [2] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece.
  • McCullough AE; Anatomic Pathology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA.
  • Chen B; Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
  • Psyrri A; 1] Hellenic Cooperative Oncology Group (HeCOG), Laskaridou 1, 11524 Athens, Greece [2] Second Department of Internal Medicine Propaedeutic, Oncology Section, Attikon University Hospital, University of Athens Medical School, 1 Rimini Street, Haidari, 12462 Athens, Greece.
  • Rimm DL; Department of Pathology, Yale University School of Medicine, 310 Cedar Street BML116, New Haven, CT 06520, USA.
  • Perez EA; Department of Hematology/Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Br J Cancer ; 111(6): 1065-71, 2014 Sep 09.
Article em En | MEDLINE | ID: mdl-25117817
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Receptores ErbB Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Receptores ErbB Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2014 Tipo de documento: Article